FY22 largely in-line; Gradual recovery on track
遥望科技(002291)FY22&1Q23业绩交流会-调研纪要
思摩尔国际(06969)FY22 业绩会纪要-港股-调研纪要
FY22 largely in-line; Auto/VR to accelerate growth
IMAX China(01970)FY22业绩会纪要-港股20230223-调研纪要
Resilient FY22/1H23 despite industry headwinds
FY22 net margins better than expected
Fair valuation despite FY22 high earnings quality
FY22E preview; Bumpy recovery in 2023
石四药集团:强劲的1H22结果;但FY22E指引略低